Case Report: Response to Regional Melphalan via Limb Infusion and Systemic PD1 Blockade in Recurrent Myxofibrosarcoma: A Report of 2 Cases
Edmund K. Bartlett(Memorial Sloan Kettering Cancer Center), Charlotte E. Ariyan(Memorial Sloan Kettering Cancer Center)
Cited by 9
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Nivolumab plus Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2013|4.2k
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k
Alternative transcription initiation leads to expression of a novel ALK isoform in cancer
|Nature|2015|251
Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium
|The Lancet Oncology|2019|219